Rush University Medical Center
Chicago, Illinois, 60612, United States
Location status: Recruiting
Location contact
Aylin Ornelas Loredo, MMS
CONTACT
Michael Gottlieb, MD
PRINCIPAL_INVESTIGATOR
Michelle Santangelo, MS
CONTACT
NCT Number: NCT06769880
The goal of this clinical trial is to learn if using point-of-care ultrasound (POCUS) can increase participant engagement and changes in behavior among adults with risk factors for pre-symptomatic heart failure presenting to the emergency department. The main questions it aims to answer are:
1. Does POCUS increase understanding of heart failure and the likelihood to improve diet, exercise, and follow up? 2. Does POCUS improve diet, exercise, follow up, and self-efficacy at three months post-intervention?
Researchers will compare an educational intervention with versus without POCUS to see if POCUS works to improve outcomes.
Participants will:
Receive either the educational intervention alone or an educational intervention plus POCUS. They will report the difference in their understanding and likelihood to improve diet, exercise, and follow up immediately post-intervention. They will also report changes in diet, exercise, follow up, and self-efficacy at three months post-intervention.
Interested in participating?
Request Info45 year and older
All sexes
Interventional
Not applicable
Chicago, Illinois, 60612, United States
Location status: Recruiting
Aylin Ornelas Loredo, MMS
CONTACT
Michael Gottlieb, MD
PRINCIPAL_INVESTIGATOR
Michelle Santangelo, MS
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This will include the educational intervention combined with a point-of-care ultrasound
This will include only the educational intervention (without ultrasound)
Time frame: 3 Months Post-Intervention
Defined as the presence or absence of a follow up visit with a primary care provider at 3 months
Time frame: Baseline and Immediately Post-Intervention
Ordinal scale of 1 (very unlikely) to 7 (very likely)
Time frame: Baseline and Immediately Post-Intervention
Ordinal scale of 1 (no knowledge) to 7 (extremely knowledgeable)
Time frame: Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Time frame: Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Time frame: Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Time frame: Baseline, Immediately Post-Intervention, and 3 Months Post-Intervention
Time frame: Baseline and 3 Months Post-Intervention
Time frame: Baseline and 3 Months Post-Intervention
Time frame: Immediately Post-Intervention and 3 Months Post-Intervention
Ordinal scale of 1 (very unsatisfied) to 7 (very satisfied)
Time frame: 3 Months Post-Intervention
Contact information is provided by the study sponsor or research team.
Aylin Ornelas Loredo, MMS
CONTACT
Michelle Santangelo, MS
CONTACT
Rush University Medical Center
Other
Combating Health Disparities Using Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258290
Acute Coronary Syndrome, Angina Pectoris
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07087184
Cardiovascular Disease, Cardiovascular Diseases
San Francisco, California, United States
View Trial DetailsNCT06337708
Behavior, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07449325
Angina Pectoris, Cardiovascular Diseases
New Haven, Connecticut, United States
View Trial Details